Correlation of in vitro bromodeoxyuridine labeling index and DNA aneuploidy with survival or recurrence in brain-tumor patients.
There are no previous reports correlating the in vitro bromodeoxyuridine (BUdR) labeling index (LI) with the clinical outcome in patients with brain tumors. The reliability of the LI as a predictor of patient survival or recurrence was examined in this study of 66 human brain tumors (19 gliomas, 18 meningiomas, and 29 others). Anti-BUdR staining was performed on surgically extirpated tumor tissue that had been treated with BUdR as previously described. Correlation of the BUdR LI with patient survival or tumor recurrence rate was carried out by the method of Kaplan and Meier. Deoxyribonucleic acid (DNA) aneuploidy was estimated in 52 cases. The results of this study indicate that BUdR LI values correlated well with the clinical course of patients with brain tumor. In comparison with patients with higher LI's, there was both a significantly higher survival rate for tumors other than meningiomas and a higher recurrence-free rate for meningiomas in patients with LI's of less than 4% and 1%, respectively. Although there was a tendency for patients without tumor aneuploidy to show better survival data than the others, no statistical difference was observed. These results suggest that the in vitro BUdR labeling method is reliable for prediction of a patient's prognosis, whereas prognosis on the basis of DNA aneuploidy alone is uncertain.
Nishizaki
T
T
Department of Neurosurgery, Yamaguchi University School of Medicine, Japan.
Orita
T
T
Kajiwara
K
K
Ikeda
N
N
Ohshita
N
N
Nakayama
H
H
Furutani
Y
Y
Ikeyama
Y
Y
Akimura
T
T
Kamiryo
T
T
D000293:Adolescent; D000328:Adult; D000368:Aged; D000782:Aneuploidy; D001932:Brain Neoplasms / Q000235:genetics / Q000401:mortality* / Q000503:physiopathology; D001973:Bromodeoxyuridine; D002648:Child; D002675:Child, Preschool; D004273:DNA, Neoplasm / Q000235:genetics*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D013194:Staining and Labeling; D015996:Survival Rate
D004273:DNA, Neoplasm; D001973:Bromodeoxyuridine